95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.00%
Revenue growth above 1.5x FNV's 0.18%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-1.07%
Negative gross profit growth while FNV is at 3.42%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1.07%
Negative EBIT growth while FNV is at 16.78%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.07%
Negative operating income growth while FNV is at 1.64%. Joel Greenblatt would press for urgent turnaround measures.
8.72%
Net income growth at 50-75% of FNV's 12.50%. Martin Whitman would question fundamental disadvantages in expenses or demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.98%
Share count expansion well above FNV's 0.13%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
8.94%
Diluted share count expanding well above FNV's 0.13%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
22.62%
Positive OCF growth while FNV is negative. John Neff would see this as a clear operational advantage vs. the competitor.
113.34%
Positive FCF growth while FNV is negative. John Neff would see a strong competitive edge in net cash generation.
252.80%
10Y revenue/share CAGR above 1.5x FNV's 70.85%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
46.85%
5Y revenue/share CAGR above 1.5x FNV's 18.72%. David Dodd would look for consistent product or market expansions fueling outperformance.
-28.54%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
388.16%
10Y OCF/share CAGR above 1.5x FNV's 33.01%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
38.42%
5Y OCF/share CAGR 1.25-1.5x FNV's 32.25%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
-44.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
230.32%
Net income/share CAGR above 1.5x FNV's 39.99% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-14.41%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-66.75%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
1009.18%
10Y equity/share CAGR above 1.5x FNV's 38.37%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
105.03%
5Y equity/share CAGR above 1.5x FNV's 21.77%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
37.47%
Positive short-term equity growth while FNV is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-52.64%
Negative near-term dividend growth while FNV invests at 25.21%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.32%
Our AR growth while FNV is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-100.00%
Inventory is declining while FNV stands at 14.86%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.23%
Negative asset growth while FNV invests at 0.56%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.41%
We have a declining book value while FNV shows 0.36%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-10.63%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-0.92%
We cut SG&A while FNV invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.